Acute myeloid leukemia in the real world: why population-based registries are needed.

ABSTRACT: Population-based registries may provide data complementary to that from basic science and clinical intervention studies, all of which are essential for establishing recommendations for the management of patients in the real world. The same quality criteria apply for the evidence-based label, and both high representation and good data quality are crucial in registry studies. Registries with high coverage of the target population reduce the impact of selection on outcome and the subsequent problem with extrapolating data to nonstudied populations. Thus, data useful for clinical decision in situations not well covered by clinical studies can be provided. The potential clinical impact of data from population-based studies is exemplified with analyses from the Swedish Acute Leukemia Registry co

SUBMITTER: Juliusson G 

PROVIDER: S-EPMC3358248 | biostudies-literature | 2012 Apr

REPOSITORIES: biostudies-literature